Genscript Biotech Co. (OTCMKTS:GNNSF – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 5,524,500 shares, a growth of 31.8% from the April 15th total of 4,192,500 shares. Based on an average daily trading volume, of 2,900 shares, […]
/PRNewswire/ The CRISPR technology market size is forecasted to increase by USD 2.88 billion from 2021 to 2026, at a CAGR of 19.34%, according to a recent.
Enzymatic DNA synthesis is a well-established technique of DNA synthesis, which is useful in synthetic biology, genetic engineering, therapeutic antibody.